Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: Role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor

Suresh Varma Penumathsa, Srikanth Koneru, Samson Mathews Samuel, Gautam Maulik, Debasis Bagchi, Shaw Fang Yet, Venogopal P. Menon, Nilanjana Maulik

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Endothelial dysfunction and impaired angiogenesis constitute a hallmark of hypercholesterolemia. This study was designed to examine the effects of resveratrol, an antioxidant with lipid-lowering properties similar to those of statins, on neovascularization along with caveolar interaction with proangiogenic molecules in hypercholesterolemic rats. Animals were divided into: rats maintained on a normal diet (control group); rats maintained on a 5% high-cholesterol diet for 8 weeks (HC group); and rats maintained on a 5% high-cholesterol diet for 8 weeks and administered resveratrol (20 mg/kg) orally for 2 weeks (HCR group). Myocardial infarction was induced by ligating the left anterior descending artery. Herein we examined a novel method for stimulating myocardial angiogenesis by pharmacological preconditioning with resveratrol at both the capillary and arteriolar levels and the potential role of hemeoxygenase-1, endothelial nitric oxide synthase and caveolin-1 in mediating such a response. We also investigated the functional relevance of such treatment by assessing whether the induced neovascularization can help preserve left ventricle-contractile functional reserve in the setting of a chronic hypercholesterolemic condition. Four weeks after sham surgery and left anterior descending artery occlusion, rats underwent echocardiographic evaluation, which revealed improvement in ejection fraction and fractional shortening in the HCR group compared with the HC group. Left ventricular tissue sections displayed increased capillary and arteriolar density in the HCR group compared with the HC group. Western blot analysis revealed downregulation of vascular endothelial growth factor and hemeoxygenase-1 and increased association of caveolin-1 eNOS in the HC group, decreasing the availability of eNOS to the system; which was reversed with resveratrol treatment in the HCR group. This study was further validated in cardiac-specific hemeoxygenase-1-overexpressed mice assuming molecular cross-talk between the targets. Hence, our data identified potential regulators that primarily attenuate endothelial dysfunction by resveratrol therapy in hypercholesterolemic myocardium.

Original languageEnglish
Pages (from-to)1027-1034
Number of pages8
JournalFree Radical Biology and Medicine
Volume45
Issue number7
DOIs
Publication statusPublished - 1 Oct 2008
Externally publishedYes

Fingerprint

Caveolin 1
Heme Oxygenase-1
Nitric Oxide Synthase Type III
Vascular Endothelial Growth Factor A
Rats
Myocardium
Nutrition
Diet
Arteries
Cholesterol
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypercholesterolemia
Surgery
Heart Ventricles
Animals
Down-Regulation
Antioxidants
Western Blotting
Myocardial Infarction
resveratrol

Keywords

  • Angiogenesis
  • Caveolin-1
  • Endothelial nitric oxide synthase
  • Hemeoxygenase-1
  • Hypercholesterolemia
  • Myocardium
  • Resveratrol
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Biochemistry
  • Physiology (medical)

Cite this

Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium : Role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor. / Penumathsa, Suresh Varma; Koneru, Srikanth; Mathews Samuel, Samson; Maulik, Gautam; Bagchi, Debasis; Yet, Shaw Fang; Menon, Venogopal P.; Maulik, Nilanjana.

In: Free Radical Biology and Medicine, Vol. 45, No. 7, 01.10.2008, p. 1027-1034.

Research output: Contribution to journalArticle

Penumathsa, Suresh Varma ; Koneru, Srikanth ; Mathews Samuel, Samson ; Maulik, Gautam ; Bagchi, Debasis ; Yet, Shaw Fang ; Menon, Venogopal P. ; Maulik, Nilanjana. / Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium : Role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor. In: Free Radical Biology and Medicine. 2008 ; Vol. 45, No. 7. pp. 1027-1034.
@article{69418c805ba347fe86b3616f3438b03c,
title = "Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: Role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor",
abstract = "Endothelial dysfunction and impaired angiogenesis constitute a hallmark of hypercholesterolemia. This study was designed to examine the effects of resveratrol, an antioxidant with lipid-lowering properties similar to those of statins, on neovascularization along with caveolar interaction with proangiogenic molecules in hypercholesterolemic rats. Animals were divided into: rats maintained on a normal diet (control group); rats maintained on a 5{\%} high-cholesterol diet for 8 weeks (HC group); and rats maintained on a 5{\%} high-cholesterol diet for 8 weeks and administered resveratrol (20 mg/kg) orally for 2 weeks (HCR group). Myocardial infarction was induced by ligating the left anterior descending artery. Herein we examined a novel method for stimulating myocardial angiogenesis by pharmacological preconditioning with resveratrol at both the capillary and arteriolar levels and the potential role of hemeoxygenase-1, endothelial nitric oxide synthase and caveolin-1 in mediating such a response. We also investigated the functional relevance of such treatment by assessing whether the induced neovascularization can help preserve left ventricle-contractile functional reserve in the setting of a chronic hypercholesterolemic condition. Four weeks after sham surgery and left anterior descending artery occlusion, rats underwent echocardiographic evaluation, which revealed improvement in ejection fraction and fractional shortening in the HCR group compared with the HC group. Left ventricular tissue sections displayed increased capillary and arteriolar density in the HCR group compared with the HC group. Western blot analysis revealed downregulation of vascular endothelial growth factor and hemeoxygenase-1 and increased association of caveolin-1 eNOS in the HC group, decreasing the availability of eNOS to the system; which was reversed with resveratrol treatment in the HCR group. This study was further validated in cardiac-specific hemeoxygenase-1-overexpressed mice assuming molecular cross-talk between the targets. Hence, our data identified potential regulators that primarily attenuate endothelial dysfunction by resveratrol therapy in hypercholesterolemic myocardium.",
keywords = "Angiogenesis, Caveolin-1, Endothelial nitric oxide synthase, Hemeoxygenase-1, Hypercholesterolemia, Myocardium, Resveratrol, Vascular endothelial growth factor",
author = "Penumathsa, {Suresh Varma} and Srikanth Koneru and {Mathews Samuel}, Samson and Gautam Maulik and Debasis Bagchi and Yet, {Shaw Fang} and Menon, {Venogopal P.} and Nilanjana Maulik",
year = "2008",
month = "10",
day = "1",
doi = "10.1016/j.freeradbiomed.2008.07.012",
language = "English",
volume = "45",
pages = "1027--1034",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium

T2 - Role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor

AU - Penumathsa, Suresh Varma

AU - Koneru, Srikanth

AU - Mathews Samuel, Samson

AU - Maulik, Gautam

AU - Bagchi, Debasis

AU - Yet, Shaw Fang

AU - Menon, Venogopal P.

AU - Maulik, Nilanjana

PY - 2008/10/1

Y1 - 2008/10/1

N2 - Endothelial dysfunction and impaired angiogenesis constitute a hallmark of hypercholesterolemia. This study was designed to examine the effects of resveratrol, an antioxidant with lipid-lowering properties similar to those of statins, on neovascularization along with caveolar interaction with proangiogenic molecules in hypercholesterolemic rats. Animals were divided into: rats maintained on a normal diet (control group); rats maintained on a 5% high-cholesterol diet for 8 weeks (HC group); and rats maintained on a 5% high-cholesterol diet for 8 weeks and administered resveratrol (20 mg/kg) orally for 2 weeks (HCR group). Myocardial infarction was induced by ligating the left anterior descending artery. Herein we examined a novel method for stimulating myocardial angiogenesis by pharmacological preconditioning with resveratrol at both the capillary and arteriolar levels and the potential role of hemeoxygenase-1, endothelial nitric oxide synthase and caveolin-1 in mediating such a response. We also investigated the functional relevance of such treatment by assessing whether the induced neovascularization can help preserve left ventricle-contractile functional reserve in the setting of a chronic hypercholesterolemic condition. Four weeks after sham surgery and left anterior descending artery occlusion, rats underwent echocardiographic evaluation, which revealed improvement in ejection fraction and fractional shortening in the HCR group compared with the HC group. Left ventricular tissue sections displayed increased capillary and arteriolar density in the HCR group compared with the HC group. Western blot analysis revealed downregulation of vascular endothelial growth factor and hemeoxygenase-1 and increased association of caveolin-1 eNOS in the HC group, decreasing the availability of eNOS to the system; which was reversed with resveratrol treatment in the HCR group. This study was further validated in cardiac-specific hemeoxygenase-1-overexpressed mice assuming molecular cross-talk between the targets. Hence, our data identified potential regulators that primarily attenuate endothelial dysfunction by resveratrol therapy in hypercholesterolemic myocardium.

AB - Endothelial dysfunction and impaired angiogenesis constitute a hallmark of hypercholesterolemia. This study was designed to examine the effects of resveratrol, an antioxidant with lipid-lowering properties similar to those of statins, on neovascularization along with caveolar interaction with proangiogenic molecules in hypercholesterolemic rats. Animals were divided into: rats maintained on a normal diet (control group); rats maintained on a 5% high-cholesterol diet for 8 weeks (HC group); and rats maintained on a 5% high-cholesterol diet for 8 weeks and administered resveratrol (20 mg/kg) orally for 2 weeks (HCR group). Myocardial infarction was induced by ligating the left anterior descending artery. Herein we examined a novel method for stimulating myocardial angiogenesis by pharmacological preconditioning with resveratrol at both the capillary and arteriolar levels and the potential role of hemeoxygenase-1, endothelial nitric oxide synthase and caveolin-1 in mediating such a response. We also investigated the functional relevance of such treatment by assessing whether the induced neovascularization can help preserve left ventricle-contractile functional reserve in the setting of a chronic hypercholesterolemic condition. Four weeks after sham surgery and left anterior descending artery occlusion, rats underwent echocardiographic evaluation, which revealed improvement in ejection fraction and fractional shortening in the HCR group compared with the HC group. Left ventricular tissue sections displayed increased capillary and arteriolar density in the HCR group compared with the HC group. Western blot analysis revealed downregulation of vascular endothelial growth factor and hemeoxygenase-1 and increased association of caveolin-1 eNOS in the HC group, decreasing the availability of eNOS to the system; which was reversed with resveratrol treatment in the HCR group. This study was further validated in cardiac-specific hemeoxygenase-1-overexpressed mice assuming molecular cross-talk between the targets. Hence, our data identified potential regulators that primarily attenuate endothelial dysfunction by resveratrol therapy in hypercholesterolemic myocardium.

KW - Angiogenesis

KW - Caveolin-1

KW - Endothelial nitric oxide synthase

KW - Hemeoxygenase-1

KW - Hypercholesterolemia

KW - Myocardium

KW - Resveratrol

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=51549090151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51549090151&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2008.07.012

DO - 10.1016/j.freeradbiomed.2008.07.012

M3 - Article

C2 - 18694817

AN - SCOPUS:51549090151

VL - 45

SP - 1027

EP - 1034

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

IS - 7

ER -